Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) has been assigned an average rating of “Moderate Buy” from the eleven brokerages that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation, five have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $128.00.
ADUS has been the subject of a number of recent research reports. Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Barclays upped their price target on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research report on Wednesday, July 8th. Bank of America reiterated a “neutral” rating and issued a $125.00 price objective (down from $140.00) on shares of Addus HomeCare in a research report on Monday, September 14th. Citigroup lowered shares of Addus HomeCare from a “market outperform” rating to a “neutral” rating in a research note on Monday, September 14th. Finally, Royal Bank Of Canada raised their price target on shares of Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th.
Check Out Our Latest Research Report on ADUS
Addus HomeCare Trading Down 0.8%
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its quarterly earnings data on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, topping the consensus estimate of $1.70 by $0.03. The firm had revenue of $377.41 million for the quarter, compared to analyst estimates of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. Addus HomeCare’s quarterly revenue was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.49 earnings per share. On average, equities analysts forecast that Addus HomeCare will post 6.3 earnings per share for the current year.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the business. Tidal Investments LLC acquired a new position in shares of Addus HomeCare during the second quarter valued at $664,000. Integrated Wealth Concepts LLC lifted its holdings in Addus HomeCare by 22.4% in the second quarter. Integrated Wealth Concepts LLC now owns 2,965 shares of the company’s stock worth $298,000 after purchasing an additional 542 shares during the period. Squarepoint Ops LLC grew its position in Addus HomeCare by 40.4% in the 2nd quarter. Squarepoint Ops LLC now owns 21,219 shares of the company’s stock valued at $2,132,000 after buying an additional 6,102 shares in the last quarter. Nykredit A S bought a new position in Addus HomeCare in the 2nd quarter valued at about $110,000. Finally, Amundi increased its stake in Addus HomeCare by 37.9% during the 2nd quarter. Amundi now owns 3,955 shares of the company’s stock valued at $397,000 after buying an additional 1,087 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.
Addus HomeCare Company Profile
Addus HomeCare Corporation provides home-based care services to older adults, people with disabilities and individuals with chronic or complex medical needs. The company operates through three primary service lines: personal care, hospice and home health.
Its personal care services include assistance with daily living activities, such as bathing, dressing, meal preparation and household tasks. Addus also provides hospice care for individuals with terminal illnesses, as well as home health services that may include skilled nursing, therapy and other clinical support.
Further Reading
- Five stocks we like better than Addus HomeCare
- Cintas Raises Guidance as a Major Catalyst Moves Closer
- 3 Space Stocks to Watch as SpaceX Reshapes the Launch Market
- Dave’s Success Has Investors Split
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
